Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Gains and Losses on Derivatives in Cash Flow Hedging Relationships Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Foreign currency borrowings and forward contracts Foreign Exchange Contract [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Net Investment Hedging Net Investment Hedging [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Intangible Assets Excluding Goodwill [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible asset amortization expense Amortization of Intangible Assets Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Total intangible asset amortization expense (including impairment charges) Amortization Income Tax Disclosure [Abstract] Income Tax Contingency [Table] Income Tax Contingency [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario, Forecast [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Jai Pharma Limited Jai Pharma Limited [Member] Jai Pharma Limited Tax Period [Axis] Tax Period [Axis] Tax Period [Domain] Tax Period [Domain] Indefinite Indefinite [Member] Indefinite amount of time 2016 through 2035 Future years [Member] Future years [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] U.S. Federal Tax Authority U.S. Federal Tax Authority [Member] U.S. Federal Tax Authority [Member] U.S. State Tax Authority U.S. State Tax Authority [Member] U.S. State Tax Authority [Member] Foreign Foreign Tax Authority [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] foreign tax credits limited to 80% of foreign taxes paid that are properly attributable to GILTI and that have no carryforward or carryback permitted for excess foreign tax credits foreign tax credits limited to 80% of foreign taxes paid that are properly attributable to GILTI and that have no carryforward or carryback permitted for excess foreign tax credits foreign tax credits limited to 80% of foreign taxes paid that are properly attributable to GILTI and that have no carryforward or carryback permitted for excess foreign tax credits Amount of goodwill expected to be tax deductible Business Acquisition, Goodwill, Expected Tax Deductible Amount Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Valuation allowance, amount Deferred Tax Assets, Valuation Allowance Net operating loss carryforwards Operating Loss Carryforwards foreign deductible attributes - carried-forward indefinitely foreign deductible attributes - carried-forward indefinitely foreign deductible attributes - carried-forward indefinitely Capital loss carryforward Capital Loss Carryforward Capital loss carryforward. Credit carryforward Tax Credit Carryforward, Amount Unrecognized tax benefit Unrecognized Tax Benefits Unrecognized tax benefits that impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Accrued interest and penalties Income Tax Examination, Penalties and Interest Accrued Interest expense (income) related to uncertain tax positions Income Tax Examination, Interest Expense Amount of unrecognized deferred tax liability Increase in Unrecognized Tax Benefits is Reasonably Possible Deduction limit of GILTI tax Deduction limit of GILTI tax Deduction limit of GILTI tax Net tax provision due to enactment of the Tax Cuts and Jobs Act Net tax provision due to enactment of the Tax Cuts and Jobs Act Net tax provision due to enactment of the Tax Cuts and Jobs Act of 2017 Expense on remeasurement of deferred taxes under Tax Act 2017 Expense on remeasurement of deferred taxes under Tax Act 2017 Expense on remeasurement of deferred taxes under Tax Act 2017 Transition tax expense recognized on enactment of U.S. Tax Act 2017 Transition tax expense recognized on enactment of U.S. Tax Act 2017 Transition tax expense recognized on enactment of U.S. Tax Act 2017 Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Accounting Policies [Abstract] Summary Of Significant Accounting Policies Significant Accounting Policies [Text Block] Compensation and Retirement Disclosure [Abstract] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Pension Benefits Pension Plan [Member] Other Postretirement Benefits Other Postretirement Benefit Plan [Member] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Projected Benefit Obligation, Expected Long-term Return on Assets Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Expected Long-term Return on Assets Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Statement of Financial Position [Abstract] Condensed Balance Sheet Statement [Table] Condensed Balance Sheet Statement [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Mylan N.V. Parent Company [Member] Mylan Inc. Subsidiary Issuer [Member] Guarantor Subsidiaries Guarantor Subsidiaries [Member] Non-Guarantor Subsidiaries Non-Guarantor Subsidiaries [Member] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Eliminations Consolidation, Eliminations [Member] Condensed Balance Sheet Statements, Captions [Line Items] Condensed Balance Sheet Statements, Captions [Line Items] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, Net, Current Inventories Inventory, Net Intercompany receivables Due from Related Parties, Current Prepaid expenses and other current assets Deferred Tax Assets, Net and Other Assets, Current Deferred Tax Assets, Net and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Investments in subsidiaries Equity Method Investments Intercompany notes and interest receivable Notes Receivable, Related Parties, Current Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Other assets Deferred Tax Asset, Net and Other Assets Deferred Tax Asset, Net and Other Assets Total assets Assets Liabilities and Equity Liabilities and Equity [Abstract] Current and liabilities Liabilities, Current [Abstract] Trade accounts payable Accounts Payable, Trade, Current Short-term borrowings Short-term Debt Income taxes payable Accrued Income Taxes, Current Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Intercompany payables Accounts Payable, Related Parties Other current liabilities Deferred Tax Liabilities, Net and Other Liabilities, Current Deferred Tax Liabilities, Net and Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Intercompany notes payable Notes Payable, Related Parties Other long-term obligations Deferred Tax Liabilities, Net and Other Long-term Obligations Deferred Tax Liabilities, Net and Other Long-term Obligations Total liabilities Liabilities Equity Equity [Abstract] Total equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and equity Liabilities and Equity Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Other Pension Plan, Postretirement or Supplemental Plans [Member] Other Pension Plan, Postretirement or Supplemental Plans [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return on Plan Assets Plan curtailment, settlement and termination Defined Benefit Plan, Curtailments Amortization of prior service costs included in SG&A Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax Recognized net actuarial losses Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case [Domain] Litigation Case [Domain] EU Commission Proceedings Perindorpril EU Commission Proceedings Perindorpril [Member] EU Commission Proceedings Perindorpril EU Commission Proceedings Citalopram EU Commission Proceedings Citalopram [Member] EU Commission Proceedings Citalopram Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Mylan Laboratories Limited Subsidiaries [Member] Mylan Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of defendants Loss Contingency, Number of Defendants Loss contingency accrual Loss Contingency, Damages Paid, Value Damages awarded Loss Contingency, Damages Awarded, Value Loss contingency accrual Loss Contingency Accrual Statement [Table] Statement [Table] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Scenario, Previously Reported [Member] Scenario, Previously Reported [Member] Restatement Adjustment [Member] Restatement Adjustment [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent [Member] Senior Notes Two Thousand Eighteen - 3.0 Percent 2016 Senior Notes (1.350% coupon) SeniorNotesTwoThousandSixteen1.35Percent [Member] Senior notes two thousand sixteen - 1.35 percent 2018 Senior Notes (2.600%) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] 2019 Senior Notes (2.550%) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2023 Senior Notes (4.200%) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent 2043 Senior Notes (5.400%) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three 2019 Senior Notes (2.500%) SeniorNotesTwoThousandNineteen2.50Precent [Member] 2019 Senior Notes (2.500%) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent 2021 Senior Notes (3.150%) SeniorNotesTwoThousandTwentyOne3.15Precent [Member] 2021 Senior Notes 3.15% 2026 Senior Notes (3.950%) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% 2046 Senior Notes (5.250%) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] Statement [Line Items] Statement [Line Items] Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Unrecognized actuarial (gain)/loss Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax Amortization of actuarial (gain)/loss Defined Benefit Plan, Amortization of Gains (Losses) Unrecognized prior service costs Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss), Net Prior Service Cost (Credit), before Tax Amortization of prior service costs Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), Net of Tax Impact of foreign currency translation OtherComprehensiveIncomeDefinedBenefitPlanForeignCurrencyTranslationBeforeTax Other Comprehensive Income Defined Benefit Plan Foreign Currency Translation Before Tax Net change Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax Commitments [Abstract] Commitments. Operating Leases, Rent Expense, Net Operating Leases, Rent Expense, Net Cash Flow Hedging [Member] Cash Flow Hedging [Member] AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Net unrealized gain on marketable securities, net of tax Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Net unrecognized gains/(losses) and prior service cost related to defined benefit plans, net of tax Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax Net unrecognized losses on derivatives in cash flow hedging relationships, net of tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Tax Foreign currency translation adjustment Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Fair Value Hedging [Member] Fair Value Hedging [Member] Interest rate swaps Interest Rate Swap [Member] Foreign currency forward contracts Cash conversion feature of Cash Convertible Notes Cash Conversion Feature Of Cash Convertible Notes [Member] Cash conversion feature of cash convertible notes. Purchased cash convertible note hedge Purchased Cash Convertible Note Hedge [Member] Purchased cash convertible note hedge. Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Other expense Other Expense [Member] Amount of Gain or (Loss) Recognized in Earnings on Hedging Items Gain (Loss) on Fair Value Hedges Recognized in Earnings Amount of Gain or (Loss) Recognized in Earnings on Derivatives Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Income Statement [Abstract] Revenues: Revenue, Net [Abstract] Net sales Sales Revenue, Goods, Net Other revenues Other Revenue, Net Total revenues Revenue, Net Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement Total operating expenses Operating Expenses Earnings from operations Operating Income (Loss) Interest expense Interest Expense Other (income) expense, net Other Nonoperating Income (Expense) Earnings before income taxes and noncontrolling interest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax provision Income Tax Expense (Benefit) Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Net earnings attributable to the noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Mylan N.V. ordinary shareholders Net Income (Loss) Available to Common Stockholders, Basic Earnings per ordinary share attributable to Mylan N.V. ordinary shareholders Earnings Per Share [Abstract] Basic (in USD per share) Earnings Per Share, Basic Diluted (in USD per share) Earnings Per Share, Diluted Weighted average ordinary shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Diluted Weighted Average Number of Shares Outstanding, Diluted Segment Reporting [Abstract] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Third party net sales Sales Revenue, Net [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] McKesson Corporation McKesson Corporation [Member] McKesson Corporation [Member] AmeriSourceBergen Corporation AmeriSourceBergen Corporation [Member] AmeriSourceBergen Corporation Cardinal Health Inc Cardinal Health Inc [Member] Cardinal Health Inc [Member] Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Concentration risk, percentage Concentration Risk, Percentage Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Operations Nature of Operations [Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instrument Designated as Hedging Instrument [Member] Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Fair value hedging relationships Cash flow hedging relationships Derivative [Line Items] Derivative [Line Items] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of Derivative Instruments on the Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Maturities Of Available-for-Sale Debt Securities At Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Period [Axis] Period [Axis] Period [Axis] Period [Domain] Period [Domain] [Domain] for Period [Axis] Trailing Four Quarters Trailing Four Quarters [Member] Trailing Four Quarters Three Full Fiscal Quarters Following Qualifying Acquisition Three Full Fiscal Quarters Following Qualifying Acquisition [Member] Three Full Fiscal Quarters Following Qualifying Acquisition [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] 2016 Senior Revolving Credit Facility 2016 Senior Revolving Credit Facility [Member] 2016 Senior Revolving Credit Facility [Member] Line of Credit Line of Credit [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt Instrument, Covenant Description Debt Instrument, Covenant Description Line of credit base interest rate Line of credit base interest rate Line of credit base interest rate Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Guarantor Obligations, Triggering Amount Guarantor Obligations, Triggering Amount Guarantor Obligations, Triggering Amount Line of Credit Facility, Interest Rate During Period Line of Credit Facility, Interest Rate During Period Line of Credit Facility, Commitment Fee Percentage Line of Credit Facility, Commitment Fee Percentage Line of Credit Facility, Fair Value of Amount Outstanding Line of Credit Facility, Fair Value of Amount Outstanding Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Meda AB Meda AB [Member] Meda AB [Member] EPD Business Abbott Laboratories [Member] Abbott Laboratories Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted average common shares outstanding Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Inventories (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Identified intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Goodwill (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Other assets (including equity method investment) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Other assets (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Total assets acquired (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Total Assets Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Current Liabilities (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Liabilities Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Deferred tax liabilities (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Other noncurrent liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Other noncurrent liabilities (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Net assets acquired (Measurement Pd Adj) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired Goodwill and Liabilities Assumed Net Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] North America Generics [Member] North America Generics [Member] North America Generics [Member] North America Specialty [Member] North America Specialty [Member] North America Specialty [Member] Europe Segment Europe Segment [Member] Europe Segment Rest of World Segment Rest of World Segment [Member] Rest of World Segment Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Product rights and licenses Licensing Agreements [Member] Topicals Business Topicals Business [Member] Topicals Business Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles In-process research and development Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Discount rate used in valuation of in-process research and development Fair Value Inputs, Discount Rate Impairment of products rights and licenses intangible assets Impairment of Intangible Assets, Finite-lived Fair value loss (gain) Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability Goodwill, Impaired, Accumulated Impairment Loss Goodwill, Impaired, Accumulated Impairment Loss Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Other Liabilities, Current [Abstract] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other current liabilities Other Current Liabilities [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Accrued Sales Allowances Other Current Accrued Sales Allowances Other Current Certain sales allowances and other adjustments that are paid to indirect customers. Employee-related Liabilities, Current Employee-related Liabilities, Current Estimated Litigation Liability, Current Estimated Litigation Liability, Current Restructuring Reserve, Current Restructuring Reserve, Current Compulsory acquisition proceeding liability Compulsory acquisition proceeding liability Compulsory acquisition proceeding liability Other current liabilities Other Liabilities, Current Interest Payable, Current Interest Payable, Current Liability derivatives, fair value Derivative Liability, Fair Value, Gross Liability Other Accrued Liabilities, Current Other Accrued Liabilities, Current Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Meda and EPD Business Meda and EPD Business [Member] Meda and EPD Business [Member] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Total revenues Business Acquisition, Pro Forma Revenue Net earnings Business Acquisition, Pro Forma Net Income (Loss) Basic (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Diluted (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Diluted North America Segment North America Segment [Member] North America Segment Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Bridge Loan Bridge Loan [Member] Swedish krona denominated contracts Swedish krona denominated contracts [Member] Swedish krona denominated contracts [Member] Business acquisition, shares tendered, percentage [Axis] Business acquisition, shares tendered, percentage [Axis] Business acquisition, shares tendered, percentage [Axis] Business acquisition, shares tendered, percentage [Domain] Business acquisition, shares tendered, percentage [Domain] [Domain] for Business acquisition, shares tendered, percentage [Axis] Twenty percent of number of shares tendered Twenty percent of number of shares tendered [Member] Twenty percent of number of shares tendered [Member] Eighty percent of number of shares tendered Eighty percent of number of shares tendered [Member] Eighty percent of number of shares tendered [Member] Net assets acquired Foreign Currency Exchange Rate, Translation Foreign Currency Exchange Rate, Translation Business acquisition, number of shares tendered Business acquisition, number of shares tendered Business acquisition, number of shares tendered Cash paid for shares tendered Cash paid for shares tendered Cash paid for shares tendered Compulsory acquisition proceeding award per share Compulsory acquisition proceeding award per share Compulsory acquisition proceeding award per share Compulsory acquisition award statutory interest rate Compulsory acquisition award statutory interest rate Compulsory acquisition award statutory interest rate Compulsory acquisition proceeding payment Compulsory acquisition proceeding payment Compulsory acquisition proceeding payment Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Business combination, share conversion ratio Business combination, share conversion ratio Number of Mylan N.V. Shares Issued Per Meda Share Business Acquisition, Share Price Business Acquisition, Share Price Acquisition purchase price Business Combination, Consideration Transferred Consideration transferred, shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Stockholders' Equity, Other Stockholders' Equity, Other Stock Issued During Period, Value, Acquisitions Stock Issued During Period, Value, Acquisitions Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Debt Related Commitment Fees and Debt Issuance Costs Debt Related Commitment Fees and Debt Issuance Costs Business combination, fair value inventory step-up Business combination, fair value inventory step-up Business combination, fair value inventory step-up Acquired intangible assets, weighted average useful life, in years Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquisitions and measurement period adjustments (1) Goodwill, Acquired During Period Other Payments to Acquire Businesses Other Payments to Acquire Businesses Total revenues Net earnings Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Net sales Sales Revenue, Goods, Net [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Central Nervous System and Anesthesia Central Nervous System [Member] Central Nervous System [Member] Respiratory and Allergy Respiratory and Allergy [Member] Respiratory and Allergy Infectious Disease Infectious Disease [Member] Infectious Disease Cardiovascular Cardiovascular [Member] Cardiovascular [Member] Gastrointestinal Gastrointestinal [Member] Gastrointestinal [Member] Diabetes and Metabolism Diabetes and Metabolism [Member] Diabetes and Metabolism Oncology Oncology [Member] Oncology Women's Healthcare Women's Healthcare [Member] Women's Healthcare Dermatological Dermatological [Member] Dermatological Immunology Immunological Agents [Member] Immunological agents Other Other Products [Member] Other Products [Member] Product Information [Line Items] Product Information [Line Items] Therapeutic class disclosure threshold Therapeutic Class Reporting Threshold Threshold for disclosure of individual therapeutic class, percentage of total category Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Fair value of financial instruments Derivative Asset, Fair Value, Gross Asset Receivables, Net, Current [Abstract] Receivables, Net, Current Receivables, Net, Current Other Receivables, Net, Current Other Receivables, Net, Current Accounts Receivable, Net, Current Pioglitazone Pioglitazone [Member] Pioglitazone [Member] Number of complaints Loss Contingency, Number of Complaints Loss Contingency, Number of Complaints Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] 2018 Floating Rate Euro Notes 2018 Floating Rate Euro Notes [Member] 2018 Floating Rate Euro Notes [Member] 2020 Floating Rate Euro Notes [Domain] 2020 Floating Rate Euro Notes [Domain] 2020 Floating Rate Euro Notes [Domain] 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Foreign currency translation Foreign Currency Transaction Gain (Loss), Unrealized Debt, Current Debt, Current Fair value of long-term debt Debt Instrument, Fair Value Disclosure Long-term debt Long-term Debt Balance Sheet Components [Abstract] Balance Sheet Components Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Defined Benefit Pension Plan, Liabilities, Noncurrent Defined Benefit Pension Plan, Liabilities, Noncurrent Other long-term obligations Other Liabilities, Noncurrent Liability for Uncertainty in Income Taxes, Noncurrent Liability for Uncertainty in Income Taxes, Noncurrent Liabilities, Other than Long-term Debt, Noncurrent Liabilities, Other than Long-term Debt, Noncurrent Convertible Debt Convertible Debt [Member] July 2020 Senior Notes Senior Notes Two Thousand Twenty [Member] Senior Notes Two Thousand Twenty [Member] Cash Convertible Notes Cash Convertible Notes [Member] Cash convertible notes. Earnings Per Common Share Attributable To Mylan Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Receivables Facility Receivables Facility [Member] Receivables facility. Commercial Paper Program [Member] Commercial Paper Program [Member] Commercial Paper Program [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Commercial Paper Issuance Commercial Paper Issuance Commercial Paper Issuance Commercial Paper, at Carrying Value Commercial Paper, at Carrying Value Projected benefit obligation, beginning of year Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Projected benefit obligation, beginning of year Defined Benefit Plan, Benefit Obligation Participant contributions DefinedBenefitPlanContributionsByPlanParticipantsBenefitObligation Defined Benefit Plan Contributions By Plan Participants Benefit Obligation Transferred liabilities Defined Benefit Plan, Assets Transferred to (from) Plan Acquisitions Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation Plan settlements and terminations Defined Benefit Plan, Settlements, Benefit Obligation Actuarial losses (gains) Defined Benefit Plan, Actuarial Gain (Loss) Benefits paid Defined Benefit Plan, Benefits Paid Impact of foreign currency translation Defined Benefit Plan, Foreign Currency Exchange Rate Gain (Loss) Projected benefit obligation, end of year Change in Plan Assets Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Fair value of plan assets, beginning of year Defined Benefit Plan, Fair Value of Plan Assets Actual return on plan assets Defined Benefit Plan, Actual Return on Plan Assets Company contributions Defined Benefit Plan, Contributions by Employer Participant contributions Defined Benefit Plan, Contributions by Plan Participants Acquisitions Defined Benefit Plan, Business Combinations and Acquisitions, Plan Assets Plan settlements Defined Benefit Plan, Settlements, Plan Assets Other Defined Benefit Plan, Other Costs Impact of foreign currency translation Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Defined Benefit Plan, Foreign Currency Translation Impact on Plan Assets Fair value of plan assets, end of year Funded status of plans Defined Benefit Plan, Funded Status of Plan Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Valuation and Qualifying Accounts [Abstract] Schedule II - Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Restructuring and Related Activities [Abstract] Restructuring and Related Costs [Table Text Block] Restructuring and Related Costs [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Gains and Losses on Marketable Securities Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Defined Pension Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Other Comprehensive Earnings (Loss) Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Net unrealized gains on marketable securities, net of tax, beginning of period Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period Foreign currency translation adjustment, beginning of period Accumulated other comprehensive loss, net of tax, beginning of period Other comprehensive (loss) earnings before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Interest expense Other (expense) income, net Amortization of actuarial loss included in SG&A Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax Net other comprehensive earnings (loss), before tax Other comprehensive earnings (loss), before tax Other Comprehensive Income (Loss), before Tax Income tax related to items of other comprehensive (loss) earnings, derivatives Net unrecognized gains (losses) on derivatives, net of tax, end of period Net unrealized gains on marketable securities, net of tax, end of period Net unrealized gains on marketable securities, net of tax, end of period Foreign currency translation adjustment, end of period Accumulated other comprehensive loss, net of tax, end of period Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Net unrealized (loss) gain on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Income tax provision Other Comprehensive Income (Loss), Tax Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Short-term Debt [Line Items] U.K. Competition and Markets Authority Proceedings Paroxetine U.K. Competition and Markets Authority Proceedings Paroxetine [Member] U.K. Competition and Markets Authority Proceedings Paroxetine Collaborations [Abstract] Collaborations [Abstract] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition [Domain] Asset Acquisition [Domain] [Domain] for Asset Acquisition [Axis] Respiratory delivery platform Respiratory delivery platform [Member] Respiratory delivery platform [Member] Supply Commitment [Axis] Supply Commitment [Axis] Supply Commitment Arrangement [Domain] Supply Commitment Arrangement [Domain] Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration Fiscal Year 2017 Fiscal Year 2017 [Member] Fiscal Year 2017 [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement Collaborative Arrangement [Member] Momenta Momenta [Member] Momenta [Member] Theravance Biopharma [Member] Theravance Biopharma [Member] Theravance Biopharma Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Number of drugs Number of drugs Number of drugs Payments To Acquire Collaborative Agreement Payments To Acquire Collaborative Agreement Payments To Acquire Collaborative Agreement Research and Development Expense Momenta collaboration prepaid expenses Momenta collaboration prepaid expenses Momenta collaboration prepaid expenses Available-for-sale securities Available-for-sale Securities Insulin Analog Products Insulin Analog Products Insulin Analog Products Euro Senior Notes Euro Senior Notes [Member] Euro Senior Notes [Member] Debt Instrument, Unamortized Discount Debt Instrument, Unamortized Discount Mark-to-market gain Long-term Debt, Gross Long-term Debt, Gross Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Basis Spread on Variable Rate Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES India INDIA The Netherlands NETHERLANDS Other foreign Other foreign [Member] Other foreign [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Released as a result of exceed performance targets [Axis] Released as a result of exceed performance targets [Axis] Released as a result of exceed performance targets [Axis] Released as a result of exceed performance targets [Domain] Released as a result of exceed performance targets [Domain] [Domain] for Released as a result of exceed performance targets [Axis] Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] Subject to Market Conditions [Axis] Subject to Market Conditions [Domain] Subject to Market Conditions [Domain] [Domain] for Subject to Market Conditions [Axis] Not Subject to Market Conditions [Member] Not Subject to Market Conditions [Member] Not Subject to Market Conditions [Member] Program Name [Axis] Program Name [Axis] Program Name Program Name [Domain] Program Name [Domain] [Domain] for Program Name 2014 Program 2014 Program [Member] 2014 Program Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Long Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock options Employee Stock Option [Member] Stock appreciation rights and performance shares Stock appreciation rights and performance shares [Member] Stock appreciation rights and performance shares Stock appreciation rights Stock Appreciation Rights (SARs) [Member] Restricted stock Restricted Stock [Member] Restricted Stock Awards Restricted Stock Units (RSUs) [Member] Performance Shares Performance Shares [Member] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Domain] Vesting Period [Domain] [Domain] for Vesting Period [Axis] Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] Vest ratably in five years or less [Member] Vest after three years Vest in three years or less [Member] Vest in three years or less Cliff vest over various periods between two and six years [Member] Cliff vest over various periods between two and six years [Member] Cliff vest over various periods between two and six years [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Common stock shares reserved for issuance to employees Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Average remaining contractual term for options outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value for options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value for options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value for options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Number of shares under stock awards converted Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period Conversion of stock, shares issued Conversion of Stock, Shares Issued Share-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award Total unrecognized compensation expense, net of estimated forfeitures Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period over which total unrecognized compensation expense expected to be recognized (years) Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Shares granted under 2015 program Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Business Combination [Abstract] Business Combination [Abstract] Research and Development Expense Research and Development Expense [Member] Series of Individually Immaterial Business Acquisitions [Member] Series of Individually Immaterial Business Acquisitions [Member] ColdEeze ColdEeze [Member] Cold-Eeze Other companies Other Companies [Member] Other companies Joint development and marketing agreement Joint development and marketing agreement Joint development and marketing agreement Acquisition related costs Business Acquisition, Transaction Costs Cash paid to acquire asset Payments to Acquire Businesses, Gross Payments made in current year Business Acquisition, expected future payment, next twelve months Expected future payments in 2017 Business Acquisition, expected future payment, year two Principles of Consolidation Policy Consolidation, Policy [Policy Text Block] Use of Estimates in the Preparation of Financial Statements Policy Use of Estimates, Policy [Policy Text Block] Foreign Currencies Policy Foreign Currency Transactions and Translations Policy [Policy Text Block] Cash and Cash Equivalents Policy Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities Policy Marketable Securities, Policy [Policy Text Block] Concentrations of Credit Risk Policy Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventories Policy Inventory, Policy [Policy Text Block] Property, Plant and Equipment Policy Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets and Goodwill Policy Goodwill and Intangible Assets, Policy [Policy Text Block] Intangible Assets and Goodwill Policy Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Contingent Consideration Policy Business Combinations Policy [Policy Text Block] Impairment of Long-Lived Assets Policy Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Revenue Recognition Policy Revenue Recognition, Policy [Policy Text Block] Research and Development Policy Research and Development Expense, Policy [Policy Text Block] Income Taxes Policy Income Tax, Policy [Policy Text Block] Earnings Per Common Share Policy Earnings Per Share, Policy [Policy Text Block] Stock-Based Compensation Policy Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Derivatives Policy Derivatives, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other Assets, Noncurrent [Abstract] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Schedule of Other Assets [Table] Other assets Other Assets [Member] Agila Specialties Agila Specialties Private Limited [Member] Agila Specialties Private Limited Schedule of Other Assets [Line Items] Schedule of Other Assets [Line Items] [Line Items] for Schedule of Other Assets [Table] Other long-term assets Other long-term assets Other long-term assets Other Assets, Noncurrent Other Assets, Noncurrent Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Securitized accounts receivable Accounts Receivable from Securitization Short-term borrowings Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Statement of Comprehensive Income [Abstract] Other comprehensive earnings (loss), before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Change in unrecognized gain and prior service cost related to defined benefit plans Net unrecognized gain (loss) on derivatives in cash flow hedging relationships Other comprehensive earnings (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive earnings attributable to the noncontrolling interest Comprehensive earnings (loss) attributable to Mylan N.V. ordinary shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Restructuring and Related Activities Disclosure [Text Block] Restructuring and Related Activities Disclosure [Text Block] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Defined Benefit Plan, Asset Categories [Axis] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Plan Asset Categories [Domain] Cash and cash equivalents Cash and Cash Equivalents [Member] Equity securities Equity Securities [Member] Fixed income securities Fixed Income Securities [Member] Assets held by insurance companies and other Assets held by insurance companies and other [Member] Assets held by insurance companies and other [Member] Fair value of plan assets Derivative [Table] Derivative [Table] Reclassification [Axis] Reclassification [Axis] Reclassification [Axis] Reclassification [Domain] Reclassification [Domain] [Domain] for Reclassification [Axis] Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) [Member] Contingent consideration Contingent Consideration [Member] Contingent Consideration. April 2013 Swaps April 2013 Swaps [Member] April 2013 Swaps [Member] August 2014 Swaps August 2014 Swaps [Member] August 2014 Swaps [Member] September 2015 Swaps Effective Date June 2016 September 2015 Swaps Effective Date June 2016 [Member] September 2015 Swaps Effective Date June 2016 [Member] September 2015 Swaps Effective Date November 2016 September 2015 Swaps Effective Date November 2016 [Member] September 2015 Swaps Effective Date November 2016 [Member] 2018 Senior Notes (3.000% coupon) 2020 Senior Notes (3.750% coupon) Notional amount of derivative Derivative, Notional Amount Maximum length of time hedged in cash flow hedge, in years Maximum Length of Time Hedged in Cash Flow Hedge Derivative instruments, gain (loss) reclassification from AOCE to income, estimated net amount to be transferred Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Amount of Ineffectiveness on Net Investment Hedges Amount of Ineffectiveness on Net Investment Hedges Loss on Cash Flow Hedge Ineffectiveness Loss on Cash Flow Hedge Ineffectiveness Derivative, Loss on Derivative Derivative, Loss on Derivative Amount of loss recognized in earnings on derivatives Derivative, Gain (Loss) on Derivative, Net Aggregate principal amount Debt Instrument, Face Amount Debt instrument, interest rate at period end Debt Instrument, Interest Rate, Effective Percentage Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Rate used to discount net cash inflows to present values Purchase consideration, contingent consideration, maximum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Payments for contingent consideration Payments of Merger Related Costs, Financing Activities Purchase consideration, contingent consideration Litigation Settlement, Amount Litigation Settlement, Amount Acquisitions Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Accretion Accretion Expense Change in contingent consideration, increase Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset Contingent consideration payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Share-Based Incentive Plan Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Net sales Sales [Member] Interest expense Interest Expense [Member] Other income Amount of Loss Reclassified from AOCE into Earnings (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain Excluded from the Assessment of Hedge Effectiveness Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Accounts receivable, net Trade and Other Accounts Receivable, Policy [Policy Text Block] Inventories Schedule of Inventory, Current [Table Text Block] Other current assets Other Current Assets [Text Block] Property, plant and equipment Property, Plant and Equipment [Table Text Block] Other assets Schedule of Other Assets, Noncurrent [Table Text Block] Trade accounts payable Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Other current liabilities Schedule of Accrued Liabilities [Table Text Block] Other noncurrent liabilities Other Noncurrent Liabilities [Table Text Block] 2016 Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months 2017 Defined Benefit Plan, Expected Future Benefit Payments, Year Two 2018 Defined Benefit Plan, Expected Future Benefit Payments, Year Three 2019 Defined Benefit Plan, Expected Future Benefit Payments, Year Four 2020 Defined Benefit Plan, Expected Future Benefit Payments, Year Five Thereafter Defined Benefit Plan, Expected Future Benefit Payments, Five Fiscal Years Thereafter Total Expected Future Benefit Payments Expected Future Benefit Payments Current assets (excluding inventories) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired Goodwill and Liabilities Assumed Net Total assets acquired (Measurement Pd Adj) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Summary of Long-Term Debt Schedule of Debt [Table Text Block] Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Income Taxes Income Tax Disclosure [Text Block] Minimum number of former shareholders providing services Business Combinations, Contingency, Number of Shareholders Providing Services Business Combinations, Contingency, Number of Shareholders Providing Services Number of shareholders Business Combination, Contingency, Number of Shareholders Business Combination, Contingency, Number of Shareholders Post-acquisition consulting services period Business Combination, Post Acquisition Consulting Services Period Business Combination, Post Acquisition Consulting Services Period Working capital and other adjustments excluded Working capital and other adjustments excluded Working capital and other adjustments excluded Expected cost to complete Expected cost to complete Expected cost to complete Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Sagent Agila Sagent Agila [Member] Sagent Agila Equity method investments Equity Method Investments [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Number of equity method investments Number of equity method investments Number of equity method investments Impairment of Equity Method Investments Impairment of Equity Method Investments Impairment of Equity Method Investments Reduction in Equity Method Investment Long-Term Obligation Reduction in Equity Method Investment Long-Term Obligation Reduction in Equity Method Investment Long-Term Obligation Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Loss from equity method investments Income (Loss) from Equity Method Investments Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital Condensed Statement of Comprehensive Income [Table] Condensed Statement of Comprehensive Income [Table] Condensed Statement of Income Captions [Line Items] Condensed Statement of Income Captions [Line Items] Condensed Consolidating Balance Sheet Condensed Balance Sheet [Table Text Block] Condensed Consolidating Statement of Operations Condensed Income Statement [Table Text Block] Condensed Consolidating Statement of Comprehensive Earnings Condensed Statement of Comprehensive Income [Table Text Block] Condensed Consolidating Statement of Cash Flows Condensed Cash Flow Statement [Table Text Block] Contractual Rights Contractual Rights [Member] Number of products Number Of Products Inventory, Net [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories Prepaid Expense and Other Assets, Current [Abstract] Prepaid expenses Prepaid Expense, Current Restricted cash Restricted Cash and Cash Equivalents, Current Available-for-sale securities Available-for-sale Securities, Current Trading securities Trading Securities Other current assets Other Assets, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] 2017 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2018 Operating Leases, Future Minimum Payments, Due in Two Years 2019 Operating Leases, Future Minimum Payments, Due in Three Years 2020 Operating Leases, Future Minimum Payments, Due in Four Years 2021 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total operating lease minimum commitments Operating Leases, Future Minimum Payments Due Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Operating Segments Operating Segments [Member] Corporate (Other) Corporate, Non-Segment [Member] Other revenue Segment Reconciling Items [Member] Intersegment revenue Intersegment Eliminations [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total revenues Net sales Segment profitability Number of reportable segments Number of Reportable Segments Number of Countries in which Entity Operates Number of Countries in which Entity Operates Segment Information Segment Reporting Disclosure [Text Block] Product Liability Product Liability [Member] Product Liability Future Amortization 2018 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Future Amortization 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Two Future Amortization 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Three Future Amortization 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Four Future Amortization 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Five Condensed Income Statement [Table] Condensed Income Statement [Table] Condensed Income Statements, Captions [Line Items] Condensed Income Statements, Captions [Line Items] Cost of sales Income tax (benefit) provision Earnings of equity interest subsidiaries Income (Loss) from Subsidiaries, Net of Tax Mature within one year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Mature in one to five years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Mature in five years and later Available for Sale Securities Debt Maturities after Five Years and Later Fair Value Available for sale securities debt maturities after five years and later fair value. Available-for-sale securities, debt securities Available-for-sale Securities, Debt Securities Collaborative Arrangement Disclosure [Text Block] Collaborative Arrangement Disclosure [Text Block] Contingencies Legal Matters and Contingencies [Text Block] Increase in the benefit obligation Defined Benefit Plan, Effect of One Percentage Point Increase on Accumulated Postretirement Benefit Obligation Decrease in the benefit obligation Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation Increase in the aggregate of service and interest cost components of annual expense Defined Benefit Plan, Effect of One Percentage Point Increase on Service and Interest Cost Components Decrease in the aggregate of service and interest cost components of annual expense Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components Condensed Cash Flow Statement [Table] Condensed Cash Flow Statement [Table] Condensed Cash Flow Statements, Captions [Line Items] Condensed Cash Flow Statements, Captions [Line Items] Non-cash transactions Other Significant Noncash Transaction, Value of Consideration Given Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Change in restricted cash Increase (Decrease) in Restricted Cash Cash paid for acquisitions, net Payments to Acquire Businesses, Net of Cash Acquired Proceeds from sale of assets and subsidiaries Proceeds from Divestiture of Businesses Payments for non designated derivative instrument, investing activities Payments for non designated derivative instrument, investing activities Payments for non designated derivative instrument, investing activities Cash paid for Meda's unconditional deferred payment Purchase of marketable securities Payments to Acquire Marketable Securities Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Payments to Acquire Other Investments Payments to Acquire Other Investments Payments to Acquire Notes Receivable Payments to Acquire Notes Receivable Repayment of Notes Receivable from Related Parties Repayment of Notes Receivable from Related Parties Payments for (Proceeds from) Other Investing Activities Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Proceeds from Dividends Received Proceeds from Dividends Received Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payment of financing fees Payments of Financing Costs Payments for Repurchase of Common Stock Payments for Repurchase of Common Stock Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Proceeds from convertible note hedge Proceeds from Hedge, Financing Activities Proceeds from Issuance of Long-term Debt Proceeds from Issuance of Long-term Debt Repayments of Long-term Debt Repayments of Long-term Debt Proceeds from exercise of stock options Proceeds from Stock Options Exercised Taxes paid related to net share settlement of equity awards Payments Related to Tax Withholding for Share-based Compensation Contingent consideration payments Proceeds from Contributed Capital Proceeds from Contributed Capital Capital payments to affiliates Payments of Distributions to Affiliates Payments on borrowings from affiliates Proceeds from Related Party Debt Repayments of Related Party Debt Repayments of Related Party Debt Other items, net Proceeds from (Payments for) Other Financing Activities Acquisition of noncontrolling interest Payments to Noncontrolling Interests Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash and Cash Equivalents Net (decrease) increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents — beginning of period Cash and cash equivalents — end of period Lorazepam and Clorazepate Lorazepam And Clorazepate [Member] Lorazepam And Clorazepate. Found in violation of antitrust laws Found In Violation of Antitrust Laws [Member] Found by jury to be in violation of antitrust laws Health insurers Health Insurers [Member] Health insurers Judgment reflects trebling of compensatory damages Judgment Reflects Trebling Of Compensatory Damages [Member] Judgment reflects trebling of compensatory damages in original verdict Original verdict Original Verdict [Member] Original verdict Original verdict plus punitive damages Original Verdict Plus Punitive Damages [Member] Original verdict plus punitive damages Self-funded customers voluntarily dismissed Self-funded Customers Voluntarily Dismissed [Member] Self-funded customers voluntarily dismissed Self-funded customers Self-Funded Customers [Member] Self-funded customers Bond Surety Bond [Member] Estimated Litigation Liability Estimated Litigation Liability Number of other actions consolidated Number of other actions consolidated Number of other actions consolidated Loss Contingency Accrual, Period Increase (Decrease) Loss Contingency Accrual, Period Increase (Decrease) Number of plaintiffs Loss Contingency, Number of Plaintiffs Damages sought Loss Contingency, Damages Sought, Value Voluntary remittitur from plaintiffs Voluntary remittitur from plaintiffs The voluntary remittitur from plaintiffs Bond Bond, Value Bond, value Current assets Equity Method Investment, Summarized Financial Information, Current Assets Noncurrent assets Equity Method Investment, Summarized Financial Information, Noncurrent Assets Total assets Equity Method Investment, Summarized Financial Information, Assets Current liabilities Equity Method Investment, Summarized Financial Information, Current Liabilities Noncurrent liabilities Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities Total liabilities Equity Method Investment, Summarized Financial Information, Liabilities Net assets Equity Method Investment Summarized Financial Information, Net Assets Equity Method Investment Summarized Financial Information, Net Assets Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Basic earnings per ordinary share attributable to Mylan N.V. ordinary shareholders Total dilutive shares outstanding Diluted earnings per ordinary share attributable to Mylan N.V. ordinary shareholders Stock Awards Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Stock-Based Compensation Plans, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Financial Instruments And Risk Management Financial Instruments Disclosure [Text Block] Other Foreign Operations Other [Member] Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Extinguishment of Debt [Axis] Extinguishment of Debt [Axis] Extinguishment of Debt, Type [Domain] Extinguishment of Debt, Type [Domain] Interest Paid Interest Paid Write off of financing fees Write off of Deferred Debt Issuance Cost Apicore [Member] Apicore [Member] Apicore [Member] Schedule of Purchase Price Allocation Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Changes in carrying amount of goodwill Schedule of Goodwill [Table Text Block] Components of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Product rights and licenses by therapeutic category Product Rights And Licenses By Therapeutic Category [Table Text Block] Product rights and licenses by therapeutic category Finite-lived Intangible Assets Amortization Expense [Table Text Block] Finite-lived Intangible Assets Amortization Expense [Table Text Block] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Deferred Base Salary Deferred Base Salary [Member] Deferred Base Salary [Member] Deferred Bonus Deferred Bonus [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Accumulated other comprehensive income expected to be recognized as net periodic benefit costs Defined Benefit Plan, Future Amortization of Gain (Loss) Future unrecognized actuarial losses Defined Benefit Plan, Future Amortization of Prior Service Cost (Credit) Unrecognized net actuarial losses exceed higher of market value of plan assets or the projected benefit obligation at the beginning of the year Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Accumulated net actuarial losses exceed higher of market value of plan assets or PBO Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Defined benefit plan, ultimate health care cost trend rate Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year Defined benefit plan, ultimate health care cost trend rate, projected Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Defined contribution plan, maximum annual contribution per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Total employer contributions Defined Contribution Plan, Cost Recognized Multiemployer plans, withdrawal obligation Multiemployer Plans, Withdrawal Obligation Award Date [Axis] Award Date [Axis] Award Date [Domain] Award Date [Domain] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Vesting [Axis] Vesting [Axis] Vesting [Domain] Vesting [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of shares under stock awards, outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Weightedaverage exercise price per share, outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Number of shares under stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Weighted average exercise price per share, granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Number of shares under stock awards, exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Weighted average exercise price per share, exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of shares under stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted average exercise price per share, forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of shares under stock awards, outstanding at end of period Weighted average exercise price per share, outstanding at end of period Number of shares under stock awards, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Weighted average exercise price per share, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Number of shares under stock awards, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average exercise price per share, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price Projected benefit obligation Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit Obligation Accumulated benefit obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation Defined Benefit Pension Plans with Projected Benefit Obligation In Excess of Plan Assets Aggregate Projected Benefit Obligation Fair value of plan assets Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Fair Value of Plan Assets Total revenues Equity Method Investment, Summarized Financial Information, Revenue Gross (loss) profit Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) Operating and non-operating expense Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations Net loss Equity Method Investment, Summarized Financial Information, Net Income (Loss) Schedule of Components of Income Tax Provision Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Statutory Tax Rate to Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Deferred tax assets, employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies Deferred tax assets, accounts receivable allowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Deferred tax assets, tax credits and loss carryforwards Deferred Tax Assets, Tax Credit Carryforwards Deferred Tax Assets, Deferred tax expense, interest expense Deferred Tax Assets, Deferred tax expense, interest expense Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from interest expense. Deferred tax assets, intangible assets and goodwill Deferred Tax Assets Intangible Assets Deferred Tax Assets Intangible Assets Deferred tax assets, other Deferred Tax Assets, Other Total deferred tax assets, gross Deferred Tax Assets, Gross Valuation allowance Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Deferred tax liabilities, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Deferred tax liabilities, intangible assets Deferred Tax Liabilities, Intangible Assets Deferred tax liabilities, other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Deferred tax assets (liabilities), net Deferred Income Tax Liabilities, Net Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of restricted stock awards, nonvested beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted average grant-date fair value per share, nonvested beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Number of restricted stock awards, nonvested ending balance Weighted average grant-date fair value per share, nonvested ending balance Modafinil Antitrust Litigation and FTC Inquiry Modafinil Antitrust Litigation and FTC Inquiry [Member] Modafinil Antitrust Litigation and FTC Inquiry. Modafinil Antitrust Litigation Settlement Modafinil Antitrust Litigation Settlement [Member] Modafinil Antitrust Litigation Settlement [Member] Other drug manufacturers Payments for Legal Settlements Payments for Legal Settlements Other liabilities Other Liabilities Other Liabilities, Noncurrent Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] [Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class Finite-lived intangible assets, net Finite-Lived Intangible Assets, Net Cash and cash equivalents Accounts receivable, net Inventories Prepaid expenses and other current assets Property, plant and equipment, net Deferred income tax benefit Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Liabilities Liabilities [Abstract] Current liabilities: Trade accounts payable Income taxes payable Deferred income tax liability Deferred Tax Liabilities, Net, Noncurrent Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Mylan N.V. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Ordinary shares — nominal value €0.01 per share as of December 31, 2016 and December 31, 2015 Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Stockholders Equity Parent Before Treasury Stock Stockholders Equity Parent Before Treasury Stock Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock. Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Less: Treasury stock — at cost Treasury Stock, Value Total equity Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired Goodwill and Liabilities Assumed Net Number of states Number of states Number of states Statement of Stockholders' Equity [Abstract] Common Stock Common Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Retained Earnings Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Noncontrolling Interest Noncontrolling Interest [Member] Common Stock, Value, Issued Balance Balance (in shares) Shares, Issued Other comprehensive (loss) earnings, net of tax Common stock share repurchase Treasury Stock, Value, Acquired, Cost Method Common stock share repurchase (in shares) Treasury Stock, Shares, Acquired Stock options exercised, net of shares tendered for payment Stock Issued During Period, Value, Stock Options Exercised Stock options exercised, net of shares tendered for payment (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Shares issued in warrant settlement Stock Issued During Period, Shares, Other Stock Issued During Period, Value, Other Stock Issued During Period, Value, Other Issuance of restricted stock, net of shares withheld (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Tax benefit of stock option plans Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Exchange of Mylan Inc. Common Stock into Mylan N.V. Ordinary Shares Exchange of Mylan Inc. Common Stock into Mylan N.V. Ordinary Shares Exchange of Mylan Inc. Common Stock into Mylan N.V. Ordinary Shares Exchange of Mylan Inc. Common Shares into Mylan N.V. Ordinary Shares, Cost Exchange of Mylan Inc. Common Shares into Mylan N.V. Ordinary Shares, Cost Exchange of Mylan Inc. Common Shares into Mylan N.V. Ordinary Shares, Cost Issuance of Ordinary Shares to Mylan N.V. Issuance of Ordinary Shares to Mylan N.V. Issuance of Ordinary Shares to Mylan N.V. Stock Issued During Period, Shares, Acquisitions Stock Issued During Period, Shares, Acquisitions Treasury Stock, Shares, Retired Treasury Stock, Shares, Retired Treasury Stock, Retired, Cost Method, Amount Treasury Stock, Retired, Cost Method, Amount Other Balance Balance (in shares) Additional Paid in Capital Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Accounting Policies [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2014-09 [Member] Subsequent Event [Member] Subsequent Event [Member] Reduction in Terminal Revenue [Axis] Reduction in Terminal Revenue [Axis] Reduction in Terminal Revenue [Axis] Reduction in Terminal Revenue [Domain] Reduction in Terminal Revenue [Domain] [Domain] for Reduction in Terminal Revenue [Axis] Accounts Receivable Accounts Receivable [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Machinery and equipment Machinery and Equipment [Member] Buildings and improvements Building and Building Improvements [Member] Capitalized software Software and Software Development Costs [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Old Warrants Old Warrants [Member] Old Warrants [Member] New Warrants New Warrants [Member] New Warrants [Member] Accounting Policies [Line Items] Property, Plant and Equipment [Line Items] Revenue Recognition, Revenue Reductions [Policy Text Block] New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income Concentration risk, number of major customers Concentration risk, number of major customers Concentration risk, number of major customers Property, plant and equipment, estimated service life (years) Property, Plant and Equipment, Useful Life Finite-lived intangible asset, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Aggregate amount of warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price of warrants issued Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted average ordinary shares issued to settle warrants Weighted average ordinary shares issued to settle warrants Weighted average ordinary shares issued to settle warrants Warrants exchanged in amended transaction Number of warrants exchanged Number of warrants exchanged Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Weighted Average Number Diluted Shares Outstanding Adjustment Share repurchased during period, shares Share repurchased during period, value Repurchase authorization, value Treasury Stock Acquired, Repurchase Authorization Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Deferred income tax benefit Deferred Income Tax Expense (Benefit) Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Unrealized losses on acquisition-related foreign currency derivatives Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Stock-based compensation expense Share-based Compensation Other non-cash items Other Noncash Income (Expense) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Income taxes Increase (Decrease) in Income Taxes Payable Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Cash flows from investing activities: Payments for product rights and other, net Settlement of acquisition-related foreign currency derivatives Cash flows from financing activities: Proceeds from issuance of long-term debt Payment of long-term debt Purchase of common stock Supplemental disclosures of cash flow information — Supplemental Cash Flow Elements [Abstract] Non-cash transactions: Noncash Investing and Financing Items [Abstract] Ordinary shares issued for acquisition Cash paid during the period for: Supplemental Cash Flow Information [Abstract] Income taxes Income Taxes Paid Interest Accumulated Other Comprehensive Income (Loss) Pretax Amounts Not Yet Reclassified in Net Periodic Benefit Cost Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block] Change in Accumulated Income (Loss) Relating to Defined Benefit Pension and Other Postretirement Benefits Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Net Accrued Benefit Costs Classification on Balance Sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Plans with Accumulated Benefit Obligation in Excess of Plan Assets Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block] Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Schedule of Assumptions Used Schedule of Assumptions Used [Table Text Block] Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates [Table Text Block] Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Subsegments [Axis] Subsegments [Axis] Subsegments [Domain] Subsegments [Domain] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Asset Class [Axis] Asset Class [Axis] Fair Value by Asset Class [Domain] Asset Class [Domain] Money market funds Money Market Funds [Member] Equity securities — exchange traded funds Exchange Traded Funds [Member] Available-for-sale fixed income investments Debt Securities [Member] U.S. Treasuries US Treasury Securities [Member] Corporate bonds Corporate Bond Securities [Member] Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Asset-backed Securities [Member] Asset-backed Securities [Member] Other Other Debt Obligations [Member] Total available-for-sale equity securities Marketable securities Interest rate swap derivatives Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Interest rate swap derivative assets Derivative Asset Total assets at recurring fair value measurement Assets, Fair Value Disclosure Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Contingent consideration Other Liabilities, Fair Value Disclosure Total liabilities at recurring fair value measurement Financial and Nonfinancial Liabilities, Fair Value Disclosure Intellectual Property Developed Technology Rights [Member] Loss Contingency, Patents Allegedly Infringed, Number Loss Contingency, Patents Allegedly Infringed, Number Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Schedule of Third Party Net Sales by Major Customers Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Net Third Party Sales Classified Based on Therapeutic Product Categories Revenue from External Customers by Products and Services [Table Text Block] Net Third Party Sales Classified Based on Geographic Location of Subsidiaries Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Debt securities Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair Value Schedule of Goodwill [Table] Schedule of Goodwill [Table] Reduction in Terminal Value Growth Rate [Domain] Reduction in Terminal Value Growth Rate [Domain] Reduction in Terminal Value Growth Rate [Domain] Increased Discount Rate [Domain] Increased Discount Rate [Domain] Increased Discount Rate [Domain] In Process Research and Development [Member] Goodwill [Member] Goodwill [Member] Goodwill [Line Items] Goodwill [Line Items] Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Goodwill, Purchase Accounting Adjustments Goodwill, Purchase Accounting Adjustments Goodwill, gross, beginning balance Goodwill, Gross Accumulated impairment losses, beginning balance Goodwill, Transfers Goodwill, Transfers Reclassifications Goodwill, Other Increase (Decrease) Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Goodwill, gross, ending balance Accumulated impairment losses, ending balance Goodwill, net, ending balance Goodwill, Impaired, Change in Estimate Description Goodwill, Impaired, Change in Estimate Description Fair Value Inputs, Long-term Revenue Growth Rate Fair Value Inputs, Long-term Revenue Growth Rate Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Fair Value Inputs, Long-term Revenue Growth Rate, Terminal Year Fair Value Inputs, Earnings before Interest, Taxes, Depreciation, and Amortization Multiple Fair Value Inputs, Earnings before Interest, Taxes, Depreciation, and Amortization Multiple Equity Interest Type [Axis] Equity Interest Type [Axis] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Mylan N.V. Mylan N.V. [Member] Mylan N.V. Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] CommonStockToOrdinaryShares CommonStockToOrdinaryShares [Member] CommonStockToOrdinaryShares [Member] Common stock, conversion basis Conversion of Stock, Shares Converted Voting interest acquired, percentage Net earnings attributable to Mylan N.V. ordinary shareholders Fair Value Disclosures [Abstract] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Balance at beginning of period Payments Balance at end of period Noncurrent assets Defined Benefit Plan, Assets for Plan Benefits, Noncurrent Current liabilities Pension and Other Postretirement Defined Benefit Plans, Current Liabilities Noncurrent liabilities Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent Net accrued benefit costs Net accrued benefit costs Net accrued benefit costs Foreign Tax Authority Non-U.S. state tax authority Non-U.S. state tax authority [Member] Non-U.S. state tax authority [Member] Domestic Tax Authority Domestic Tax Authority [Member] U.S. Federal Current Current Federal Tax Expense (Benefit) U.S. Federal Deferred Deferred Federal Income Tax Expense (Benefit) Income tax provision (benefit), U.S. Federal Federal Income Tax Expense (Benefit), Continuing Operations U.S. State Current Current State and Local Tax Expense (Benefit) U.S. State Deferred Deferred State and Local Income Tax Expense (Benefit) Income tax provision (benefit), U.S. State State and Local Income Tax Expense (Benefit), Continuing Operations Non-U.S. Current Current Foreign Tax Expense (Benefit) Non-U.S. Deferred Deferred Foreign Income Tax Expense (Benefit) Income tax provision (benefit), Non-U.S. Foreign Income Tax Expense (Benefit), Continuing Operations Earnings (loss) before income taxes and noncontrolling interest: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Earnings before income taxes and noncontrolling interest, foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Earnings before income taxes and noncontrolling interest, United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2016 Term Loans 2016 Term Loans [Member] 2016 Term Loans [Member] Base interest rate Long-term Debt, Weighted Average Interest Rate Long-term Debt, Weighted Average Interest Rate Repayments of Debt Repayments of Debt Debt Instrument, Interest Rate During Period Debt Instrument, Interest Rate During Period LUXEMBOURG LUXEMBOURG Luxembourg U.S. Branch Luxembourg U.S. Branch [Member] Luxembourg U.S. Branch [Member] GIBRALTAR GIBRALTAR IRELAND IRELAND Other Foreign Operations Non-US [Member] Clean energy and research credits Effective Income Tax Rate Reconciliation Equity Investment Effective Income Tax Rate Reconciliation Equity Investment Rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Tax Act - deferred tax rate change Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent State income taxes and credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Other Foreign Operations Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Merger of foreign subsidiaries Effective Income Tax Rate Reconciliation, India Amagulation Effective Income Tax Rate Reconciliation, India Amagulation Effective tax rate Effective Income Tax Rate Reconciliation, Percent Employee Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Patents and technologies Patents [Member] Other Other Intangible Assets [Member] Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Finite-lived intangible assets, net book value In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Intangible assets, net book value, excluding goodwill Ordinary shares, par value, in USD per share Common Stock, Par or Stated Value Per Share Ordinary shares, number of shares authorized Common Stock, Shares Authorized Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Inventory Valuation Reserves Inventory Valuation Reserves Sales Allowances Current Sales Allowances Current Sales allowances that are recorded in a contra account to accounts receivable. Valuation Allowances and Reserves, Balance Valuation Allowances and Reserves, Balance Capitalized Computer Software, Net Capitalized Computer Software, Net Depreciation Depreciation Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense Net realizable value of inventory recognized as expense Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation allowance for deferred tax assets Valuation Allowance of Deferred Tax Assets [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Beginning balance Additions Charged to Costs and Expenses Valuation Allowances and Reserves, Additions for Charges to Cost and Expense Additions Charged to Other Accounts Valuation Allowances and Reserves, Additions for Charges to Other Accounts Deductions Valuation Allowances and Reserves, Deductions Ending balance Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Axis] Debt Instrument Maturity Date [Domain] Debt Instrument Maturity Date [Domain] Debt Instrument Maturity Date [Domain] 2019 2019 [Member] 2019 [Member] 2018 2018 [Member] 2018 [Member] Bank Loan Obligations Bank Loan Obligations [Member] Current portion of long-term debt Current Portion of Long-Term Debt [Member] Medium-term Notes Medium-term Notes [Member] Meda Bank Loans MedaBankLoanTwoBillionKr [Member] MedaBankLoanTwoBillionKr [Member] Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Meda Medium Term Notes MedaMediumTermNotes [Member] MedaMediumTermNotes [Member] Other Long Term Debt Other Long Term Debt [Member] Other long term debt. Unamortized Debt Issuance Expense Unamortized Debt Issuance Expense Equity Method Investments Equity Method Investments [Table Text Block] Commitments Commitments Disclosure [Text Block] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] through fiscal year 2018 through fiscal year 2018 [Member] through fiscal year 2018 [Member] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee Severance Employee Severance [Member] Other Restructuring Other Restructuring [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Payments for Restructuring Payments for Restructuring Restructuring Reserve, Period Increase (Decrease) Restructuring Reserve, Period Increase (Decrease) Restructuring and Related Cost, Incurred Cost Restructuring and Related Cost, Incurred Cost Restructuring Reserve, Translation and Other Adjustment Restructuring Reserve, Translation and Other Adjustment Restructuring and Related Cost, Cost Incurred to Date Restructuring Charges Restructuring Reserve Restructuring Reserve Document And Entity Information [Abstract] Document and Entity Information. Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Unrecognized tax benefit — beginning of year Additions for current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Additions for prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Reductions for prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Reductions due to expirations of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Addition due to acquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition Unrecognized tax benefit — end of year 2017 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2018 Long-term Debt, Maturities, Repayments of Principal in Year Two 2019 Long-term Debt, Maturities, Repayments of Principal in Year Three 2020 Long-term Debt, Maturities, Repayments of Principal in Year Four 2021 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total Pricing and Medicaid Litigation Pricing And Medicaid Litigation [Member] Pricing and Medicaid Litigation. Indemnification agreement Indemnification Agreement [Member] Mylan Specialty Mylan Specialty [Member] Mylan Specialty Accounts Payable, Current [Abstract] Accounts Payable, Trade Accounts Payable, Trade Accounts Payable, Other Accounts Payable, Other Accounts Payable, Trade, Current Amount of (Loss) Gain Recognized in Earnings on Derivatives Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Forfeiture rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Share-based compensation arrangement by Share-based payment award, fair value assumptions, Forfeiture rate Weighted average grant date fair value per option Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Unrecognized actuarial (gains) losses Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Gains (Losses), before Tax Unrecognized prior service costs Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), Net Prior Service Cost (Credit), before Tax Total Pension and Other Postretirement Benefit Plans, Accumulated Other Comprehensive Income (Loss), before Tax Foreign currency forward contracts Foreign Exchange Forward [Member] Property, Plant and Equipment [Abstract] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Land and improvements Land and Land Improvements [Member] Construction in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Schedule Of Operating Leases Operating Leases of Lessee Disclosure [Table Text Block]